Research Topics
| K M CurtisSummaryAffiliation: Centers for Disease Control and Prevention Country: USA Publications
| Collaborators
|
Detail Information
Publications
Adaptation of the World Health Organization's Selected Practice Recommendations for Contraceptive Use for the United StatesKathryn M Curtis
Division of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA Electronic address
Contraception 87:513-6. 2013..The WHO guidance includes evidence-based recommendations on common, yet sometimes complex, contraceptive management questions...
Use of combined oral contraceptives among women with migraine and nonmigrainous headaches: a systematic reviewKathryn M Curtis
WHO Collaborating Center in Reproductive Health, Division of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA
Contraception 73:189-94. 2006..The three studies that provided evidence on hemorrhagic stroke reported low or no risk associated with migraine or with COC use...- Regret following female sterilization at a young age: a systematic reviewKathryn M Curtis
WHO Collaborating Center in Reproductive Health, Division of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA
Contraception 73:205-10. 2006..Results of studies that examined risk by continuous age showed a consistent inverse relationship between women's age at sterilization and their likelihood of regretting having had the procedure... - Progestogen-only contraception and bone mineral density: a systematic reviewKathryn M Curtis
Division of Reproductive Health, WHO Collaborating Center in Reproductive Health, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA
Contraception 73:470-87. 2006..Limited evidence suggested that use of progestogen-only contraceptives other than DMPA did not affect BMD... - Neoplasia with use of intrauterine devicesKathryn M Curtis
Division of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA
Contraception 75:S60-9. 2007..Additionally, hormone-releasing IUDs or intrauterine systems (IUSs) release progestins or progesterone into the uterus. Both of these mechanisms may affect users' risk for neoplasia... - Progestogen-only contraceptive use in obese womenKathryn M Curtis
Division of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA
Contraception 80:346-54. 2009..The objective of this systematic review is to determine whether obese women who use progestogen-only contraceptives are more likely to experience weight gain or serious adverse events as compared to nonobese users... - Safety of hormonal and intrauterine methods of contraception for women with HIV/AIDS: a systematic reviewKathryn M Curtis
Division of Reproductive Health, Centers for Disease Control and Prevention, MS K 34, 4770 Buford Highway NE, Atlanta, GA 30341, USA
AIDS 23:S55-67. 2009..To determine from the literature whether HIV-infected women who use hormonal or intrauterine contraception are at increased risk of HIV disease progression, other adverse health outcomes, or HIV transmission to uninfected sexual partners... - Adaptation of the World Health Organization's medical eligibility criteria for contraceptive use for use in the United StatesKathryn M Curtis
Centers for Disease Control and Prevention, Atlanta, GA 30341, USA
Contraception 82:3-9. 2010..This guidance includes recommendations for use of specific contraceptive methods by people with certain characteristics or medical conditions... - Putting risk into perspective: the US medical eligibility criteria for contraceptive useKathryn M Curtis
Division of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA
Rev Endocr Metab Disord 12:119-25. 2011..Most women, even women with medical conditions, can safely use highly effective methods of contraception and promoting their use will further efforts to reduce unintended pregnancy... - U.S. medical eligibility criteria for contraceptive use, 2010Kathryn M Curtis
Division of Reproductive Health, Centers for Disease Control and Prevention, 4770 Buford Highway NE, Atlanta, GA 30341, USA
J Womens Health (Larchmt) 20:825-8. 2011..Most women, even those with medical conditions, can safely use most methods of contraception... - Combined oral contraceptive use among women with hypertension: a systematic reviewKathryn M Curtis
WHO Collaborating Center in Reproductive Health, Division of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA
Contraception 73:179-88. 2006..Women who did not have their blood pressure measured before initiating COC use were at higher risk for ischemic stroke and AMI, but not for hemorrhagic stroke or VTE, than COC users who did not have their blood pressure measured... - Visits to emergency departments for gynecologic disorders in the United States, 1992-1994K M Curtis
Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia 30341 3717, USA
Obstet Gynecol 91:1007-12. 1998..To assess rates of visits to emergency departments for gynecologic disorders among women of reproductive age in the United States... - Effective use of hormonal contraceptives: Part I: Combined oral contraceptive pillsKathryn M Curtis
World Health Organization Collaborating Center in Reproductive Health, Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA
Contraception 73:115-24. 2006.... - Contraception for women in selected circumstancesKathryn M Curtis
World Health Organization Collaborating Center in Reproductive Health, Centers for Disease Control and Prevention, Atlanta, Georgia 30341, USA
Obstet Gynecol 99:1100-12. 2002..To review new evidence regarding ten controversial issues in the use of contraceptive methods among women with special conditions and to present World Health Organization recommendations derived in part from this evidence... - Safety of implantable contraceptives for women: data from observational studiesKathryn M Curtis
Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, GA, USA
Contraception 65:85-96. 2002..Nonsignificantly elevated associations were reported for diabetes, serious mental disorders, and rheumatoid arthritis. Conditions for which risks were marginally, yet significantly, elevated were hypertension and gall bladder disease... - Maternal obesity and risk of cesarean delivery: a meta-analysisS Y Chu
Division of Reproductive Health, Centers for Disease Control and Prevention, Mailstop K23, 1600 Clifton Road, Atlanta, GA 30333, USA
Obes Rev 8:385-94. 2007..The meta-regression found no evidence that these estimates were affected by selected study characteristics. Our findings provide a quantitative estimate of the risk of cesarean delivery associated with high maternal body mass... - Pregnancy intention and its relationship to birth and maternal outcomesA P Mohllajee
Division of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
Obstet Gynecol 109:678-86. 2007.... - Effects of injectable or implantable progestin-only contraceptives on insulin-glucose metabolism and diabetes riskHenry S Kahn
Division of Diabetes Translation, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia 30341, USA
Diabetes Care 26:216-25. 2003..Additional research could help clarify whether exposure to injectable or implantable contraceptives leads to increased risk of type 2 diabetes and gestational diabetes in women with predisposing factors... - Reproductive history and mortality after breast cancer diagnosisMaura K Whiteman
Division of Applied Public Health Training, Epidemiology Program Office, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia 30341, USA
Obstet Gynecol 104:146-54. 2004..To assess whether reproductive factors are associated with mortality after breast cancer diagnosis... - Maternal obesity and risk of stillbirth: a metaanalysisSusan Y Chu
Division of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
Am J Obstet Gynecol 197:223-8. 2007..Maternal obesity is associated with an increased risk of stillbirth, although the mechanisms to explain this association are not clear... - Body mass and mortality after breast cancer diagnosisMaura K Whiteman
Epidemic Intelligence Service, Division of Applied Public Health Training, Epidemiology Program Office, Centers for Disease Control and Prevention, 4770 Buford Highway Northeast, Mailstop K 34, Atlanta, GA 30341 3724, USA
Cancer Epidemiol Biomarkers Prev 14:2009-14. 2005..Obesity could be a preventable risk factor for death among breast cancer patients. Further study is needed to determine how these findings might affect recommendations to reduce breast cancer mortality... - Clinical practice. Long-acting methods of contraceptionHerbert B Peterson
Department of Maternal and Child Health, School of Public Health, University of North Carolina at Chapel Hill, Chapel Hill, USA
N Engl J Med 353:2169-75. 2005 - Combined hormonal contraception and bone health: a systematic reviewSummer L Martins
Division of Reproductive Health, WHO Collaborating Center in Reproductive Health, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA
Contraception 73:445-69. 2006.... - Effective use of hormonal contraceptives: Part II: Combined hormonal injectables, progestogen-only injectables and contraceptive implantsCamaryn E Chrisman
Wake Forest University School of Medicine, Winston-Salem, NC 27157, USA
Contraception 73:125-33. 2006..Norplant implants left in place for up to seven completed years remained effective among women who weighed <70 kg at the time of implant insertion, but their effectiveness decreased among women weighing >or=70 kg... - Progestogen-only contraceptive use among women with sickle cell anemia: a systematic reviewJennifer K Legardy
WHO Collaborating Center in Reproductive Health, Division of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA
Contraception 73:195-204. 2006..Although data are limited, these studies suggest that progestogen-only contraceptives are safe for women with sickle cell anemia... - Acceptance and use of emergency contraception with standardized counseling intervention: results of a randomized controlled trialRuth Petersen
Department of Maternal and Child Health, School of Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA
Contraception 75:119-25. 2007..The objective of this work was to evaluate the acceptance, use and recall of an optional advance prescription for emergency contraception (EC)... - Hormonal contraceptive use and risk of sexually transmitted infections: a systematic reviewAnshu P Mohllajee
Centers for Disease Control and Prevention, Division of Reproductive Health, WHO Collaborating Center in Reproductive Health, Atlanta, GA 30341, USA
Contraception 73:154-65. 2006..The observed positive associations may be due to a true association or to bias, such as differential exposure to STIs by contraceptive use or increased likelihood of STI detection among hormonal contraceptive users... - Medical eligibility criteria for new contraceptive methods: combined hormonal patch, combined hormonal vaginal ring and the etonogestrel implantMary E Gaffield
Department of Reproductive Health and Research, World Health Organization, CH 1211 Geneva 27, Switzerland
Contraception 73:134-44. 2006..Limited evidence also suggests no adverse effects of the etonogestrel implant on lactation parameters or infant development among users enrolled 28 to 56 days postpartum and followed for 4 months... - Keeping up with evidence a new system for WHO's evidence-based family planning guidanceAnshu P Mohllajee
WHO Collaborating Center in Reproductive Health, Division of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, Georgia 30341, USA
Am J Prev Med 28:483-90. 2005.... - Study design to evaluate the safety and effectiveness of hormonal contraception for womenNathalie Kapp
Department of Reproductive Health and Research, World Health Organization, Geneva, Switzerland
Clin Obstet Gynecol 50:850-67. 2007..Observational studies, experimental studies, and meta-analysis in hormonal contraception are also reviewed... - Use of evidence in WHO recommendationsHerbert B Peterson
Lancet 370:825; author reply 826-7. 2007 - Does insertion and use of an intrauterine device increase the risk of pelvic inflammatory disease among women with sexually transmitted infection? A systematic reviewAnshu P Mohllajee
Division of Reproductive Health, WHO Collaborating Center in Reproductive Health, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA
Contraception 73:145-53. 2006..The absolute risk of PID was low for both groups (0-5% for those with STIs and 0-2% for those without)...